Oligonucleotides @ Bachem - Interview with Torsten Wöhr

As a full service provider, Bachem offers the entire range of CMC services and is expanding into the rapidly expanding oligonucleotide therapeutics market.
We sat down with Torsten Wöhr, Head of Oligonucleotides at Bachem to discuss the company’s strategy, its chances of success and how Bachem can benefit from our expertise in peptide synthesis.
With its peptide manufacturing background and strong analytical capabilities, Bachem is working to build a successful oligonucleotide business and grow its portfolio.
Bachem is happy to partner for projects regarding custom peptides, oligonucleotides or conjugation molecules. Learn more about our products by visiting our website today: www.bachem.com/
About Bachem:
Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. With 50 years of experience and expertise Bachem provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.
Learn more about our products and services at www.bachem.com/​​
Bachem. Leading Partner in Tides